Gå ubegrenset med Magzter GOLD

Gå ubegrenset med Magzter GOLD

Få ubegrenset tilgang til over 9000 magasiner, aviser og premiumhistorier for bare

$149.99
 
$74.99/År

Prøve GULL - Gratis

When BJP Asks 'Modi Vs Who', The Answer Is 'Modi Vs Common Man'

THE WEEK India

|

April 21, 2024

A veteran of many poll battles, Mallikarjun Kharge is facing his toughest challenge since he became Congress president in October 2022.

- SONI MISHRA, MIDHUN M. KURIAKOSE AND V.S. JAYASCHANDRAN

When BJP Asks 'Modi Vs Who', The Answer Is 'Modi Vs Common Man'

The 81-year-old is leading not just the grand old party’s campaign for the Lok Sabha polls, but also helming the opposition INDIA bloc’s fight against the formidable BJP.

THE WEEK caught up with Kharge as he took a breather on the occasion of Ugadi, the New Year’s Day for Kannadigas, at his family home ‘Samyak’ in Bengaluru. Described by a close aide of Kharge as his “recharge zone”, Samyak is where he loves to be in the midst of his children and grandchildren. After the quick break, Kharge would be off to Delhi to resume the hectic election campaign. He and Rahul Gandhi are the Team Congress’s lead pair in the poll arena.

In a detailed interview, Kharge was at his combative best as he took on Prime Minister Narendra Modi and the BJP on a range of issues—from election guarantees, the Ram Temple, the PM’s intense focus on southern states and his attacks on opposition leaders on the issue of corruption, to electoral bonds and the income tax department’s action against the Congress. He also spoke about the sudden exit of Bihar Chief Minister Nitish Kumar from the INDIA bloc, the refusal of West Bengal Chief Minister Mamata Banerjee to ally with the Congress, and the alleged tokenism that the Modi government displayed while nominating a dalit, and then an adivasi, to the country’s top constitutional post. Excerpts:

Q/ What is the significance of the 2024 Lok Sabha polls?

FLERE HISTORIER FRA THE WEEK India

THE WEEK India

THE WEEK India

Fire, smoke and soaring worries

The PSLV C-62 fiasco is a stress test of ISRO's technical systems, organisational processes and market credibility

time to read

7 mins

January 25, 2026

THE WEEK India

THE WEEK India

The dinosaur and the dictator

Dictators have a few things in common with T. rex, the king of dinosaurs. Both dominate their sphere of influence through brute force.

time to read

2 mins

January 25, 2026

THE WEEK India

We are developing master plans for tourism destinations

Across the world, the tourism development is more about providing seamless connection and basic infra like transportation, lodging and boarding.

time to read

2 mins

January 25, 2026

THE WEEK India

THE WEEK India

A TIGHTROPE WALK

As small-caps are yet to find valuation comfort, 2026 would be a challenging year for them

time to read

4 mins

January 25, 2026

THE WEEK India

THE WEEK India

ON THIN ICE

With the intensification of great-power rivalries in the region, Greenland's strategic and resource potential has become salient

time to read

5 mins

January 25, 2026

THE WEEK India

THE WEEK India

Elgin, Ephesus and Erdogan

Lord Elgin was wrong. Not the eighth earl whom we know as a viceroy of India, but his more famous father, the seventh who had carted away the Parthenon Marbles from Athens during 1802-1812. Elgin feared the Ottoman Turks, who had occupied Greece, might vandalise them.

time to read

2 mins

January 25, 2026

THE WEEK India

THE WEEK India

Art at the heart

The sixth edition of the Kochi-Muziris Biennale reclaims its legacy

time to read

6 mins

January 25, 2026

THE WEEK India

THE WEEK India

BENIGN PROSTATIC HYPERPLASIA (BPH): Understanding Symptoms, Diagnosis & Modern Treatment Options

Benign Prostatic Hyperplasia (BPH) is a very common medical condition affecting aging men, particularly those above 50 years.

time to read

2 mins

January 25, 2026

THE WEEK India

THE WEEK India

ERA OF THE NEW NORMAL

The confrontations with China and Pakistan have added another dimension to the ever-evolving nature of the Indian military

time to read

5 mins

January 25, 2026

THE WEEK India

THE WEEK India

Affordable CAR-T Therapy Brings New Hope for Blood Cancer Patients in India

For thousands of Indians battling blood cancers, a once-unimaginable dream is fast becoming reality. Cutting-edge CART cell therapy a breakthrough treatment that uses a patient's own immune system to fight cancer is now available in India at a fraction of global costs, offering renewed hope to patients with advanced disease.

time to read

1 mins

January 25, 2026

Listen

Translate

Share

-
+

Change font size